Community pharmacist-initiated screening program for osteoporosis: Randomized controlled trial
Yuksel N et al. – A pharmacist screening program as described in this study doubled the number of patients tested for osteoporosis. Nevertheless, many patients eligible for bone mineral density (BMD) did not receive appropriate care suggesting more intensive interventions are needed. Methods- Aim was to determine the effect of a community pharmacist screening program on testing and treatment of osteoporosis
- 262 pts meeting BMD testing guidelines:
- Men or women aged ≥65 yrs or 50–64 yrs with one major risk factor including previous fracture
- Family history of osteoporosis
- Glucocorticoids for >3 mo, or
- Early menopause
were allocated to intervention (129) or control (133)
- Intervention: printed materials, education, and quantitative ultrasound
- Primary outcome: a composite endpoint of BMD or prescription for osteoporosis medication within 4 mo
Results- Primary endpoint of BMD or osteoporosis treatment was achieved by 22% pts vs 11% controls
- This was driven by BMD testing (22% vs 10% for controls)
- Calcium intake increased more among intervention pts than controls (30% vs 19%)
- No effect on knowledge or quality of life
[more...]
|
|
|
